Skip to main content
TipRanks
Go Ultimate75% OFF

Nicholas Haft Insider Profile

4 Followers

Nicholas Haft, former Director at Finch Therapeutics Group, holds 4.06M shares in Finch Therapeutics Group (Ticker: FNCHQ). Most recently, Nicholas Haft Bought 63,850 shares of Finch Therapeutics Group on Dec 22, 2021 for an estimated value of $649.99K.

Nicholas Haft's Trading History

FNCHQ
Finch Therapeutics Group
Dec 22, 2021―Informative Buy649.99K$41.99M
FNCHQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 22, 2021Informative Buy$649.99K63,850$10.18-95.60%
Mar 25, 2021Informative Buy$15.00M882,351$17.00-68.40%
Mar 25, 2021Uninformative Buy$0.003,110,706$0.00―

You May Also Like

Nicholas Haft insider profile FAQ

What is the percentage of profitable transactions made by Nicholas Haft?
The percentage of profitable transactions made by Nicholas Haft is 0%.
What is the average return per transaction made by Nicholas Haft?
The average return per transaction made by Nicholas Haft is -82.00%.
What stocks does Nicholas Haft hold?
Nicholas Haft holds: FNCHQ stocks.
What was Nicholas Haft’s latest transaction?
Nicholas Haft’s latest transaction was an Informative Buy of $649.99K.
What was Nicholas Haft's most profitable transaction?
Nicholas Haft’s most profitable transaction was an Informative Buy of FNCHQ stock on March 25, 2021. The return on the trade was -68.40%.
What is Nicholas Haft's role in Finch Therapeutics Group?
Nicholas Haft's role in Finch Therapeutics Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.